FOLH1 and prostate carcinoma: Here, we describe the case of a 74-year-old male patient with a high-risk prostate carcinoma who underwent positron-emission tomography/computed tomography (PET/CT) with [68Ga]Ga-prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) for staging.